- For Print
- March 7, 2025
Listed Company Name: Eisai Co., Ltd.
Representative: Haruo Naito
Representative Corporate Officer and CEO
Securities Code: 4523
Stock Exchange Listings: Prime Market of the Tokyo Stock Exchange
Inquiries: Sayoko Sasaki
Vice President, Corporate Communications
Phone +81-3-3817-5120
Eisai Co., Ltd. announced today that the following Corporate Officers, effective April 1, 2025, were appointed by resolutions at the subsequent Board of Directors meeting held today.
1. Corporate Officers
New Responsibility | Name | Current Responsibility |
Representative Corporate Officer CEO |
Haruo Naito | As on the left |
Representative Corporate Officer Industry Affairs |
Yasushi Okada | Representative Corporate Officer Industry Affairs, China Business, Internal Audit |
Representative Corporate Officer Executive Vice President COO, Chief Growth Officer |
Keisuke Naito | As on the left |
Representative Corporate Officer |
Terushige Iike | Executive Vice President Chief Strategy and Planning Officer |
Senior Vice President President, EMEA Region, Chairman & CEO, Eisai Europe Ltd. |
Gary Hendler | As on the left |
Senior Vice President President, Americas Region, Chairman & CEO, Eisai Inc. |
Tatsuyuki Yasuno | As on the left |
Senior Vice President President, Eisai China Holdings Ltd. |
Yanhui Feng | As on the left |
Vice President Chief Clinical Officer |
Lynn Kramer | As on the left |
Vice President China Business, Japan / Asia Filing and Registration, Global Safety |
Sayoko Sasaki | Vice President Corporate Communications Sustainability |
Vice President President, Asia and Latin America Region, API Solutions |
Shohei Kanazawa | As on the left |
Vice President Production, Quality and Technology, Japan Regulatory Affairs |
Akiko Nakahama | Vice President Chief Portfolio Officer Japan / Asia Filing and Registration Chief Quality Officer Japan Regulatory Affairs |
Vice President Chief HR Officer, Corporate Communications, Sustainability, General Affairs |
Teruyuki Masaka | Vice President Chief HR Officer, General Affairs, Japan Subsidiaries |
Vice President New Supply Chain Strategy |
Mitsuo Kosaka | As on the left |
Vice President Corporate Strategy |
Shin Ujiie | As on the left |
Vice President Business Development and Global Alliance |
Toshitaka Asano | As on the left |
Vice President Chief Financial Officer |
Mitsuru Shomon | As on the left |
Vice President Chief Information Officer |
Makoto Hoketsu | As on the left |
Vice President General Counsel, Chief Compliance Officer, Intellectual Property, Internal Control |
Shin Kato | As on the left |
Vice President Japan Business |
Toshihiko Yusa | Group Officer Deputy President and Eisai Japan, LEQEMBI Special Mission, Eisai Japan |
Vice President Chief Scientific Officer |
Katsutoshi Ido | Discovery Strategy Councilor, DHBL HQs |
NOTE: Representative Corporate Officer and CEO Haruo Naito will also serve concurrently as a Director. Representative Corporate Officer Yasushi Okada will retire from the post of Corporate Officer and be appointed as a Director of the company as of June 18, 2025.
2. Changes in Representative Corporate Officers
New Position | Name | Current Responsibility |
Representative Corporate Officer, Executive Vice President |
Terushige Iike | Executive Vice President Chief Strategy and Planning Officer |
3. Nominees for New Corporate Officers
New Position | Name | Current Responsibility |
Vice President | Toshihiko Yusa | Group Officer Deputy President and Eisai Japan LEQEMBI Special Mission, Eisai Japan |
Vice President | Katsutoshi Ido | Discovery Strategy Councilor, DHBL HQs |
4. Retiring Corporate Officer
Name | Current Responsibility |
Masatomi Akana | Senior Vice President Chief Government Relations Officer, Chief IR Officer |
Takashi Owa | Senior Vice President Chief Scientific Officer Japan Medical, Safety |
Kazuhiko Tamura | Vice President President, Eisai Demand Chain Systems |
NOTE: Masatomi Akana, Takashi Owa and Kazuhiko Tamura are to be appointed as Senior Group Officers.
5. Career Summary of New Nominees for Corporate Officer
Toshihiko Yusa (April 3, 1968)
Apr. 1992 Joined Eisai
Sep. 2014 Chief of Planning Department, Eisai Japan
Apr. 2016 Chief of Regional Cooperation Tokai-Hokuriku HQ, Eisai Japan
Oct. 2018 Chief of Executive Office Section
Jun. 2019 Chief of Regional Cooperation Shuto-Ken HQ, Eisai Japan
Jan. 2020 Group Officer (Current)
AD Purpose Officer, Dementia Total Inclusive Ecosystem Business Unit
Jul. 2021 Chief of Integrated Dementia Strategy Department
Apr. 2024 Deputy President and Eisai Japan LEQEMBI Special Mission, Eisai Japan (Current)
Katsutoshi Ido (July 21, 1978)
Apr. 2003 Joined Eisai
Apr. 2018 International Project Team Discovery Lead
Apr. 2020 Global Gene Therapy Task Force Lead, Discovery, Medicine Creation, Neurology Business Group
Jul. 2021 Global Modality Exploration Task Force Lead, Discovery, Medicine Creation, Neurology Business Group
Jul. 2022 (Secondees) Director of Cambridge Office, Eisai Innovation Inc.
Apr. 2024 Head of InflammAging & Senescence Domain, DHBL
Oct. 2024 Discovery Strategy Councilor, DHBL HQs (Current)